Ontology highlight
ABSTRACT: Background
Diagnosis and monitoring of localized prostate cancer requires discovery and validation of noninvasive biomarkers. Nuclear magnetic resonance (NMR)-based metabolomics of seminal plasma reportedly improves diagnostic accuracy, but requires validation in a high-risk clinical cohort.Materials and methods
Seminal plasma samples of 151 men being investigated for prostate cancer were analyzed with 1H-NMR spectroscopy. After adjustment for buffer (add-to-subtract) and endogenous enzyme influence on metabolites, metabolite profiling was performed with multivariate statistical analysis (principal components analysis, partial least squares) and targeted quantitation.Results
Seminal plasma metabolites best predicted low- and intermediate-risk prostate can
SUBMITTER: Roberts MJ
PROVIDER: S-EPMC5693471 | biostudies-literature | 2017 Dec
REPOSITORIES: biostudies-literature